183 related articles for article (PubMed ID: 11377704)
21. Precise ultrastructural localization of in vivo deposited IgG antibodies in fresh perilesional skin of patients with bullous pemphigoid.
Sato M; Shimizu H; Ishiko A; Masunaga T; Akiyama M; Hashimoto T; Kitajima Y; Nishikawa T
Br J Dermatol; 1998 Jun; 138(6):965-71. PubMed ID: 9747356
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune response against the bullous pemphigoid 180 autoantigen.
Liu Z; Diaz LA; Giudice GJ
Dermatology; 1994; 189 Suppl 1():34-7. PubMed ID: 7519485
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
[TBL] [Abstract][Full Text] [Related]
24. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.
Liu Z; Diaz LA; Troy JL; Taylor AF; Emery DJ; Fairley JA; Giudice GJ
J Clin Invest; 1993 Nov; 92(5):2480-8. PubMed ID: 7693763
[TBL] [Abstract][Full Text] [Related]
25. Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid.
Hall RP; Murray JC; McCord MM; Rico MJ; Streilein RD
J Invest Dermatol; 1993 Jul; 101(1):9-14. PubMed ID: 8331301
[TBL] [Abstract][Full Text] [Related]
26. Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly conserved collagenous protein of the cutaneous basement membrane zone.
Li K; Guidice GJ; Tamai K; Do HC; Sawamura D; Diaz LA; Uitto J
J Invest Dermatol; 1992 Sep; 99(3):258-63. PubMed ID: 1512460
[TBL] [Abstract][Full Text] [Related]
27. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
Allen J; Shears E; Powell J; Wojnarowska F
Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
[TBL] [Abstract][Full Text] [Related]
28. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
Ghohestani RF; Claudy A
Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
[No Abstract] [Full Text] [Related]
29. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin.
Onodera Y; Shimizu H; Hashimoto T; Ishiko A; Ebihara T; Tanaka M; Nishikawa T
J Invest Dermatol; 1994 May; 102(5):686-90. PubMed ID: 8176249
[TBL] [Abstract][Full Text] [Related]
30. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid.
Seishima M; Izumi T; Kitajima Y
Eur J Dermatol; 1999; 9(1):39-42. PubMed ID: 9920986
[TBL] [Abstract][Full Text] [Related]
31. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen.
Ishiko A; Shimizu H; Masunaga T; Yancey KB; Giudice GJ; Zone JJ; Nishikawa T
J Invest Dermatol; 1998 Jul; 111(1):93-6. PubMed ID: 9665393
[TBL] [Abstract][Full Text] [Related]
32. Bullous pemphigoid and other basement membrane antigens.
Diaz LA; Anhalt GJ
Clin Dermatol; 1987; 5(1):93-109. PubMed ID: 3552197
[No Abstract] [Full Text] [Related]
33. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
[TBL] [Abstract][Full Text] [Related]
34. Blistering insights into the pathogenesis of bullous pemphigoid.
Wong HK; Bechtel MA
Clin Immunol; 2012 Feb; 142(2):101-4. PubMed ID: 22217422
[No Abstract] [Full Text] [Related]
35. Detection of autoantibodies against bullous pemphigoid and pemphigus antigens by an enzyme-linked immunosorbent assay using the bacterial recombinant proteins.
Ide A; Hashimoto T; Amagai M; Tanaka M; Nishikawa T
Exp Dermatol; 1995 Apr; 4(2):112-6. PubMed ID: 7543794
[TBL] [Abstract][Full Text] [Related]
36. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans.
Olivry T; Dunston SM; Fahey M; Nguyen N; Marinkovich MP
Vet Pathol; 2000 Jul; 37(4):302-9. PubMed ID: 10896391
[TBL] [Abstract][Full Text] [Related]
38. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
[TBL] [Abstract][Full Text] [Related]
39. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.
Schumann H; Baetge J; Tasanen K; Wojnarowska F; Schäcke H; Zillikens D; Bruckner-Tuderman L
Am J Pathol; 2000 Feb; 156(2):685-95. PubMed ID: 10666397
[TBL] [Abstract][Full Text] [Related]
40. Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2).
Olivry T; Chan LS; Xu L; Chace P; Dunston SM; Fahey M; Marinkovich MP
Vet Pathol; 1999 Jul; 36(4):328-35. PubMed ID: 10421100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
